agilon health (NYSE:AGL) Trading Down 6.6% - Should You Sell?

agilon health, inc. (NYSE:AGL - Get Free Report) shares were down 6.6% on Friday . The stock traded as low as $3.11 and last traded at $3.13. Approximately 1,039,670 shares traded hands during trading, a decline of 81% from the average daily volume of 5,475,114 shares. The stock had previously closed at $3.35.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on AGL. Barclays lowered their price objective on agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. JMP Securities cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. Macquarie began coverage on shares of agilon health in a research report on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price for the company. Sanford C. Bernstein raised their price target on shares of agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research note on Wednesday, January 15th. Finally, TD Cowen dropped their price objective on shares of agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a research note on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, agilon health presently has a consensus rating of "Hold" and an average target price of $3.95.

agilon health Stock Up 7.2 %

The firm has a 50-day moving average of $2.99 and a two-hundred day moving average of $2.98. The company has a market capitalization of $1.32 billion, a PE ratio of -3.41 and a beta of 0.67. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Activity at agilon health

In other agilon health news, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were acquired at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares of the company's stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Karen Mcloughlin acquired 25,000 shares of the company's stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares of the company's stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 77,500 shares of company stock worth $169,600. Company insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its stake in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Inspire Investing LLC raised its position in agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock valued at $413,000 after purchasing an additional 112,241 shares in the last quarter. Citigroup Inc. boosted its stake in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after buying an additional 1,941,993 shares during the period. Geode Capital Management LLC grew its position in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock worth $27,097,000 after buying an additional 84,889 shares in the last quarter. Finally, Empowered Funds LLC acquired a new position in shares of agilon health during the fourth quarter worth about $97,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.